Navigation Links
NeuMedics Invited to Speak at the Life Science Innovation Northwest 2016 in Seattle

NeuMedics Inc. is pleased to announce that CEO Iain Duncan has been invited to give a podium presentation at Life Science Innovation Northwest on June 2, 2016. The session begins at 1:10 PM and Iain will present the proof of concept data that demonstrates NeuMedics compound and propriety microemulsion can be successfully used as a topical agent and a treatment for ophthalmic complications of diabetes.

Mr. Duncan will also detail the results of a proof of principle study that was made possible through a grant from Washington State Life Science Discovery Fund.

“NM108 has a different mechanism of action than all of the anti-VEGF drugs on the market and currently in development,” says Duncan, “It targets the micro glia and short circuits the inflammation inside the eye that leads to the formation of VEGF. Our goal is to eliminate the need for intravitreal injection, the current standard of care for people who suffer from diabetic retinopathies.”

According to the U.S. Centers for Disease Control and Prevention, Diabetic Retinopathy is the leading cause of blindness in diabetics worldwide and The World Health Organization estimates 11% of the 347 million people suffering from diabetes also suffer from Diabetic Retinopathy. Intraocular injection of vascular endothelial growth factor (VEGF) inhibitors dominates the available therapies for the treatment of Diabetic Retinopathy, Diabetic Macular Edema, and Retinal Vein Occlusion. There is a significant need for effective and patient-friendly therapeutics for retinal diseases that address new cellular pathways, which can be regularly administered as an eye drop.

Event Information:

Life Science Innovation Northwest
When: June 1-2, 2016
Where: Washington State Convention Center
800 Convention Place
Seattle, WA.

About NeuMedics
NeuMedics is a specialty biopharmaceutical company based in Seattle that is focused on improving patients' lives by identifying and developing, novel therapeutics for the treatment of retinal diseases that can be safely and chronically administered as an eye drop.

For more information, please go to

Read the full story at

Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved

Related biology technology :

1. NeuMedics Inc. Selected to Present at Cavendish Global Health Impact Forum
2. Kinetiq to attend DIA China in Beijing, Quorum Review IRB invited to speak at Peking University
3. DunhamTrimmer LLC Invited Speaker on Biological Agriculture Markets at Jefferies Conference
4. Health & Technology Leaders Invited to Participate in Co-Design of Health Care Delivery
5. DunhamTrimmer LLC Invited Speaker on Biocontrol at Jefferies Conference
6. Whitehouse Laboratories Invited to Participate in INTERPHEX Live Program
7. Adaptive Biotechnologies Invited to Present at Upcoming Conferences
8. Pressure BioSciences, Inc. Invited to Present at the 2nd Global Life Sciences Conference in Warsaw, Poland
9. Dr. Ira Williams Invited To IHI 25th National Forum On Quality Improvement In Health Care
10. Garnero invited by Netanyahu to be a speaker at major Israel Biofuel Conference
11. Vet-Stem, Inc. Founder and CEO, Robert Harman, DVM, Invited to Speak at the Adult Stem Cell Therapy and Regenerative Medicine Conference
Post Your Comments:
(Date:9/11/2019)... ... 2019 , ... An upcoming episode of Advancements with Ted ... sequencing analysis. Check your local listings for more information. , Advancements will go ... and will explore its revolutionary pathogenic DNA analysis technology, which predicts in real-time, ...
(Date:9/8/2019)... , ... September 05, 2019 , ... ... Blaine Fitzgerald, former Vice President of Finance for Shopify, has been named Chief ... and healthcare venture capitalist Joel Finlayson as strategic advisors. Additionally, Spartan has hired ...
(Date:8/29/2019)... ... August 28, 2019 , ... ... Danisco® ingredient solutions to attendees at the International Baking Industry Expo, September 8 ... challenges from optimizing production efficiency to cost and waste reduction and from maintaining ...
(Date:8/25/2019)... ... 2019 , ... Authors Gopal Nayak and Mahendra Kumar Trivedi ... “Impact of Biofield Treatment on Growth and Anatomical Characteristics of Pogostemon cablin (Benth.)" ... book garnered No. 1 status on Amazon in several categories including: Mind-Body Medicine, ...
Breaking Biology Technology:
(Date:9/14/2019)... ... September 12, 2019 , ... Catalent, ... drugs, biologics, gene therapies, and consumer health products, today announced that professor David ... Dr. Schaffer has played an integral advisory role on the gene therapy industry, ...
(Date:9/11/2019)... ... September 09, 2019 , ... Greenberg Traurig, LLP ... David J. Dykeman will speak at DeviceTalks Minnesota, Sept. 9-10, at the Hyatt ... firm’s global Life Sciences & Medical Technology Group have been featured speakers ...
(Date:9/8/2019)... ... September 06, 2019 , ... ... mesenchymal stem/stromal cell (hMSC) biomanufacturing systems, today announces its release of the ... media system designed for product development. RoosterBio continues to simplify MSC production ...
Breaking Biology News(10 mins):